UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
| Date of Report (Date of earliest event reported) | November 15, 2001
|
Genetronics Biomedical Corporation
| Delaware (State or other jurisdiction of incorporation) |
0-29608 (Commission File Number) |
33-0969592 (IRS Employer Identification No.) |
| 11199 Sorrento Valley Road, San Diego California | 92121-1334 | |
| (Address of principal executive offices) | (Zip Code) |
| Registrant’s telephone number, including area code | (858) 597-6006
|
Not Applicable
| Item 5. Other Events. | ||||||||
| Item 7. Financial Statements and Exhibits. | ||||||||
| SIGNATURES | ||||||||
| EXHIBIT INDEX | ||||||||
| EXHIBIT 99.1 | ||||||||
| EXHIBIT 99.2 | ||||||||
Item 5. Other Events.
On November 30, 2001, Genetronics Biomedical Corporation completed an offering of 5,212,494 special warrants at a price of $0.45 per special warrant. The special warrants were primarily purchased by existing shareholders of the Company. Exhibit 99.1 is a press release issued to announce the execution of the agreement for the sale of the special warrants and Exhibit 99.2 is a press release issued to announce the closing of the transaction.
Item 7. Financial Statements and Exhibits.
| Exhibit | ||
| No. | Description | |
| 99.1 | Press release issued November 15, 2001 | |
| 99.2 | Press release issued December 3, 2001 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Genetronics Biomedical Corporation | ||||
| By: | /s/ Avtar Dhillon | |||
| Date: December 3, 2001 | Avtar Dhillon, Chief Executive Officer | |||
EXHIBIT INDEX
| Exhibit | ||
| No. | Description | |
| 99.1 | Press release issued November 15, 2001 | |
| 99.2 | Press release issued December 3, 2001 |